파마리서치, 1분기 영업익 572억…전년比 28.1% 증가

Pharmareach's Q1 earnings surge of 28.1% reflects strong domestic healthcare demand and expanding cosmetics exports, signaling robust recovery in Korea's pharmaceutical and medical device sectors. The company's diversified portfolio—with cosmetics generating significant overseas revenue—demonstrates how Korean health and beauty companies are strengthening their global competitiveness.